newsfilter
← Latest News
GlobeNewswire·

Avalo Therapeutics to Participate in Upcoming Investor Conferences

WAYNE, Pa., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ:AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory